Access cutting-edge crohn's disease treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels. It can cause many different symptoms including abdominal pain, diarrhea, tiredness, and weight loss. This study will assess how safe and effective oral Upadacitinib is in treating moderately to severely active Crohn's Disease in pediatric participants aged 2 to 18 years old who have had inadequate response, loss of response, intolerance, or
Sponsor: AbbVie
Check if you qualify for this crohn's disease clinical trial in New York, NY
If you're searching for crohn's disease treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.